🇺🇸 FDA
Pipeline program

Oxycodone/Naltrexone Capsules

ELI-004-2015

Phase 3 small_molecule completed

Quick answer

Oxycodone/Naltrexone Capsules for Withdrawal Symptoms is a Phase 3 program (small_molecule) at ELITE PHARMACEUTICALS INC /NV/ with 1 ClinicalTrials.gov record(s).

Program details

Company
ELITE PHARMACEUTICALS INC /NV/
Indication
Withdrawal Symptoms
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials